Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Amylyx Pharmaceuticals (AMLX) Q2 2024 Earnings
AMLX
9
May
Confirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-1.75
-1.02
-0.29
0.44
Details
Expected EPS
-0.004
Actual EPS
-1.75
Surprise EPS
-1.75
Surprise Percent
+43,650%
Description
Amylyx Pharmaceuticals (AMLX) has reported earnings of -1.75 per share for Q2 2024.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login